PAG
ENZ

Private Advisor Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Private Advisor Group’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-649
Closed -$1K – 3521
2020
Q2 		$1K Buy
+649
New +$1.67K ﹤0.01% 3778

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Advisor Group's ENZ Position: Q3 2020 in Review

Private Advisor Group sold out of Enzo Biochem, Inc. (ENZ) in Q3 2020, closing a stake of 649 shares — an estimated $1K sold.

Private Advisor Group first reported a position in ENZ in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 82 funds tracked by Wall St. Rank hold ENZ as of Q3 2020.

  • Private Advisor Group reported no remaining Enzo Biochem, Inc. position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 649 Enzo Biochem, Inc. shares in Q3 2020, an estimated $1K.
  • Private Advisor Group first reported a position in Enzo Biochem, Inc. in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Enzo Biochem, Inc. position peaked at $1K in Q2 2020.
  • 82 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.